Abstract. Ammonia is one of the important toxins produced by Helicobacter pylori (H. pylori), the major cause of peptic ulcer diseases. We examined whether glutamine or marzulene (a gastroprotective drug containing 1% sodium azulene and 99% glutamine) protects the gastric mucosa against H. pylori in vivo and investigated the mechanism underlying glutamine-induced mucosal protection against ammonia in gastric epithelial cells in vitro. Mongolian gerbils were fed for 3 months with a diet containing glutamine (2% -20%) or marzulene (20%) starting from 2 weeks or 2 years after H. pylori infection. Then, gastric mucosal changes were evaluated both macro-and microscopically. Cultured gastric epithelial cells were incubated in the presence of ammonia, with or without glutamine; and cell viability, ammonia accumulation, and chemokine production were determined. Gerbils exhibited edema, congestion, and erosion after 3-month infection; and after 2-year infection, they showed cancer-like changes in the gastric mucosa. Glutamine and marzulene significantly suppressed these pathological changes caused in the gastric mucosa by H. pylori infection. Ammonia was accumulated in the cells, resulting in an increase in chemokine production and a decrease in cell viability. These pathological responses were prevented by glutamine. In addition, glutamine decreased chemokine production and cell death through inhibition of cellular accumulation of ammonia, resulting in the prevention of H. pylori-induced gastric diseases in vivo. These results suggest that glutamine/marzulene would be useful for prophylactic treatment of H. pylori-induced gastric diseases in patients.
Introduction
Since the discovery of Helicobacter pylori (H. pylori) as the pathogenic bacteria in digestive diseases such as gastritis, gastroduodenal ulcer, and gastric cancer, many investigators have reported various deleterious factors produced by H. pylori (1 -3) . Among them, vacuolating cytotoxin (VacA), gene products of the Cag pathogenecity island (PAI), and urease-derived ammonia are now generally accepted pathogenic factors (4) . Interestingly, in addition to the original cytotoxic properties, recent reports proposed the unexpected new roles of VacA and Cag PAI gene products in the pathogenesis of H. pylori-induced gastric diseases through acting on tyrosine phosphatases and their receptors (5 -7) . However, target gene-deletion analysis revealed that not only VacA-deleted H. pylori causes severe gastritis, but CagE-or Cag PAI-deleted isogenic strains also induce gastritis in the gerbil model as well (8) . Moreover, H. felis, a related gastric Helicobacter that lacks VacA or Cag PAI but has potent urease activity, induces severe gastritis and gastric cancer in several animal models (9 -11) . These results suggest the pathogenic importance of urease-derived ammonia, rather than that of VacA or gene product of Cag PAI, in the formation of gastritis induced by H. pylori. Indeed, a number of studies showed that ammonia, at a concentration detectable in the gastric juice of H. pylori-infected patients, in hibits gastric epithelial proliferation (12) , retards restitution (13) , and induces mucosal cell death (14 -17) and by so, doing impairs the gastric mucosal barrier function.
We previously reported that glutamine added exogenously protects gastric epithelial cells against ammonia-induced cell death (16) . However, it remains still unknown whether or not glutamine is effective against H. pylori-induced diseases in vivo. In the present study, we thus examined the effect of chronic treatment with high glutamine-or marzulene-containing diet on H. pylori-induced pathological changes in the stomach and investigated the mechanisms underlying the protective action of glutamine against ammonia using cultured gastric epithelial cells in vitro.
Materials and Methods

Animals
Male Mongolian gerbils (6-week-old, 40 -50 g), purchased from Seac Yoshitomi (Fukuoka), were maintained in an isolated clean room with regulated temperature (20°C -22°C) and humidity (approximately 55%) with a 12/12-h light/dark cycle. The gerbils were fasted for 24 h before H. pylori inoculation, and drinking water was also withheld after the inoculation. Then, both food and water were freely available to the animals from 4 h after the inoculation. The animal maintenance and experimental procedures described here were approved by the Experimental Animal Research Committee of Kyoto Pharmaceutical University.
H. pylori infection to Mongolian gerbils
A cagA-and vacA-positive strain of H. pylori (TN2GF4), derived from a gastric ulcer patient, was kindly provided by Dr. Watanabe (Takeda Chemical Industries, Ltd., Osaka) (18) . The bacteria were incubated in brain-heart infusion broth (Difco, Detroit, MI, USA) containing 10% fetal bovine serum at 37°C overnight under a microaerophilic atmosphere and allowed to grow to a density of 2 × 10 8 colony-forming units (CFU) / ml. H. pylori (2 × 10 8 CFU, 1.0 ml) was orally inoculated to each animal. Normal animals received 1.0 ml of the medium alone. In a short-term gastritis study, paste foods containing 2%, 10%, and 20% (w/w) glutamine or marzulene (a gastroprotective drug containing 1% sodium azulene and 99% glutamine, prescribed in East Asian countries such as Japan, Korea, and China) were given to the gerbils twice daily (10 g/animal per day) for 3 months, starting 2 weeks after H. pylori inoculation. In a long-term gastric cancer study, the diets were given for 3 months starting from 2 years after infection. In both studies, at the end of experiments the pathological changes in the gastric mucosa were evaluated macroscopically. Paste food was made of 1.4 kg CE-2 (CLEA Japan, Tokyo), 30 g gelatin (Morinaga & Co., Ltd., Tokyo), and 1.4 l distilled water. To avoid degradation of the drugs, glutamine or marzulene was mixed with the paste food every time immediately before feeding it to the animals. Glutamine and marzulene were supplied from Kotobuki Pharmaceutical Co., Ltd. (Nagano)
Determination of viable H. pylori in stomach
The number of viable H. pylori in the gerbil stomach was assayed as reported previously (19) . After the gerbils were fasted for 24 h, they were sacrificed, and their stomachs were excised. Halves of the stomachs were homogenized in 10 ml of PBS with a Polytron (Kinematica, Steinhofhalde, Switzerland). The diluted homogenates were applied onto Helicobacter agar plates (Nissui Pharmaceutical Co., Ltd., Tokyo). The plates were incubated at 37°C under a microaerophilic atmosphere for 7 days. The number of colonies was counted, and viable H. pylori was expressed as CFU per stomach.
Evaluation of H. pylori-induced gastric damages
Gastric pathology was blindly evaluated. Normal and H. pylori-infected animals were killed, and their stomachs were excised. The stomachs were incised along the greater curvature and spread out with pins on a silicon-coated 6-cm dish and then the wet weight of the stomach, as an indicator of inflammation due to edema, was measured. Mucosal changes such as bleeding (spot/ erosion), congestion, edema, ulcer, and hyperplastic polyp (mm 2 ) were examined under a dissecting microscope (magnification, 10 ×). Thereafter, gastric specimens were cut off from the fundus near the antrum and fixed in 4% paraformaldehyde in PBS. Frozen sections (12 µm in thickness) were prepared, and neutrophil-specific myeloperoxidase activity-dependent staining and hematoxylin staining were carried out. Gastric mucosal thickness was evaluated using a microscopic scale.
Cell culture
Rat gastric epithelial cell lines, RGM1 cells established by Dr. Matsui 3 ). To investigate the mechanisms by which glutamine protects RGM1 cells against ammonia, the cells were incubated in the absence or presence of 30 mM NH 4 Cl with or without glutamine for the indicated hours and then used for determination of intracellular ammonia accumulation (6 h), chemokine production [cytokine-induced neutrophil chemoattractant (CINC/ GRO)] release (12 h) and cell viability (24 h).
To confirm that the response of RGM1 cells is generalized to human gastric epithelial cells, we used a human gastric epithelial-like cell line derived from a gastric adenocarcinoma patient, MKN74 cells (obtained from the Riken Cell Bank, Tsukuba, Japan), for determination of chemokine (interleukin-8; IL-8) production (24 h) and cell viability (96 h).
Measurement of ammonia accumulation
Since vacuolation is an indicator of the intracellular amount of weak base, we evaluated the intracellular concentration of ammonia by quantifying vacuolation. To quantify vacuolation in RGM1 cells, the uptake of neutral red into vacuoles was determined as described by Cover et al. (16, 21, 22) , with slight modification. Vacuolation was calculated as % increase compared with vehicle alone-treated cells.
Measurement of chemokine release
Chemokine releases from the cells into the culture medium were measured by commercially available ELISA kits (CINC/GRO for RGM1 cells and IL-8 for MKN74; R&D Systems, Inc., Minneapolis, MN, USA).
Measurement of cell viability
The cell viability was evaluated by a colorimetric assay using crystal violet (23), a cytochemical stain that binds to chromatin. Viability was calculated as % of vehicle alone-treated cells.
Statistical analysis
Data of in vivo study are presented as the mean ± S.E.M. from 6 to 16 gerbils per group, while those of in vitro study are the representative results from 3 different experiments and presented as the means ± S.E.M. from 4 wells. Statistical differences in the dose-response studies were evaluated by Dunnett's multiple comparison test. Student's t-test or the Mann-Whitney U test was used for the comparison between two groups. A value of P < 0.05 was regarded as significant.
Results
Effect of glutamine and marzulene on gastric damages induced by short-term H. pylori infection in gerbils
In non-infected gerbils, all the groups including control diet, glutamine at 20%, and marzulene at 20% showed no abnormal pathological changes in the gastric mucosa (Fig. 1A) . In addition, the stomach wet weight (Fig.  1B) and the gastric mucosal thickness (data not shown) were very much similar among these groups. When the gerbils were infected with H. pylori for 3 months, the control diet group showed dramatic pathological changes characterized by severe edema, congestive surface epithelium, and bleeding, vastly in the corpus and some in the antral area. In addition, the stomach wet weight (Fig.  1B) and the gastric mucosal thickness (data not shown) were significantly increased after H. pylori infection for 3 months. Histological analyses revealed extensive exfoliation of the surface epithelial cells and severe infiltration of inflammatory cells (mainly neutrophils) in the gastric mucosa. In contrast, the glutamine-treated groups exhibited a dose-dependent improvement of the pathological changes in all these parameters. Even at 2% glutamine, the pathological changes were significantly less compared with those in the control group. At 20% glutamine, the surface epithelial structure was partially recovered and the level of inflammatory cell infiltration was reduced. Likewise, marzulene at 20% also significantly reduced the pathological changes of the stomach caused by H. pylori. Interestingly, treatment with 20% glutamine caused a slight reduction in the viable H. pylori number in the stomach compared with the control, although the difference did not reach the level of bacteriological significance (Fig. 2). 
Effect of glutamine and marzulene on gastric carcinoma-like changes induced by long-term H. pylori infection in gerbils
Two-years infection with H. pylori caused carcinomalike changes in the gastric mucosa, characterized by hyperplastic polyps (Figs. 3A and 4 ) and metaplasia 28 K Amagase et al (data not shown), in addition to the changes caused by short-term H. pylori infection. Histologically, gastric atrophy, that is, the reduction in the number of gastric acid-secreting parietal cells and pepsinogen-secreting chief cells and intestinal metaplasia were also observed in the long-term-infected gastric mucosa. Three-month treatment with 20% glutamine or 20% marzulene diet alone caused no abnormal changes in the stomach in the absence of H. pylori infection. Surprisingly, feeding with 20% glutamine or 20% marzulene diet significantly reduced the total area of mucosa with such pathological changes caused by long-term H. pylori infection, especially, hyperplastic polyps. Furthermore, when the degree of each pathological change was compared among the groups, a significant difference was observed in cases of hyperplastic polyps and edema (not shown). In addition, these agents also ameliorated the increase of the stomach wet weight caused by H. pylori infection (Fig. 3B). 
Effect of glutamine on ammonia accumulation in RGM1 cells
Incubation with 30 mM NH 4 Cl for 6 h caused significant increase in the accumulation of ammonia in the cells compared with the control. When RGM1 cells were incubated with 30 mM NH 4 Cl in the presence of glutamine (0.2 -20 mM), the amount of ammonia in the cells was decreased in a concentration-dependent manner for glutamine (Fig. 5A ). This agent even at 0.2 mM significantly reduced the accumulation of ammonia in the cells and at 20 mM almost completely abolished this response.
Effect of glutamine on NH 4 Cl-induced chemokine release by RGM1 cells
The release of CINC/GRO was significantly increased when RGM1 cells were incubated with 30 mM NH 4 Cl for 12 h (Fig. 5B) . Co-incubation of glutamine concentration-dependently suppressed the increase of CINC/GRO release from RGM1 cells caused by NH 4 Cl, and this effect was significant at 2 mM or greater. 
Effect of glutamine on NH 4 Cl-induced gastric epithelial cell death in RGM1 cells
As shown in Fig. 5C , the incubation of RGM1 cells with 30 mM NH 4 Cl significantly increased the intracellular accumulation of ammonia at 6 h and the release of CINC/GRO at 12 h and decreased cell viability 24 h later. Glutamine (0.2 -20 mM) significantly mitigated the reduction of cell viability in a concentration-dependent manner and at 20 mM, almost completely restored the reduced cell viability to the level observed in the control.
Effect of glutamine and NH 4 Cl on chemokine release and cell viability of MKN74 cells
Similar to RGM1 cells, when MKN74 cells were incubated with 30 mM NH 4 Cl, IL-8, one of the chemokines, was released in the culture medium in a time-dependent manner. The levels of IL-8 observed 24 h after the incubation were significantly greater compared with those in the control. The co-incubation with glutamine even at 0.2 mM partially but significantly and at more than 2 mM totally suppressed the increase of IL-8 release caused by 30 mM NH 4 Cl (Fig. 6A) . Incubation of MKN74 cells with 30 mM NH 4 Cl also caused a significant reduction of the cell viability 96 h later. Glutamine (0.2 -20 mM) significantly prevented the reduction of cell viability in a concentration-dependent manner, the degree of prevention at 20 mM being almost 100% (Fig. 6B ).
Discussion
Non-steroidal anti-inflammatory drugs (NSAIDs) and stress are known to be the major pathogenic factors in the development of gastric lesions in rats and humans (24) . In addition, NSAIDs also delay the healing of acetic acid-induced gastric ulcer in rats (25) . Since 1970s, glutamine is reportedly known to ameliorate gastric lesions induced by such pathogenic factors (25 -29) , and this amino acid is now used clinically as a gastroprotective drug in Japan. However, the underlying mechanism of the glutamine-induced gastric protection is still unclear. H. pylori infection has been recognized as another important pathogenic factor in the development of gastritis, gastric and duodenal ulcers, and gastric cancer (2, 4), but whether glutamine is effective for the treatment of H. pylori-related gastric diseases remains unknown. It is well known that ammonia is one of the deleterious toxins produced by H. pylori (2, 4, 12 -14, 17, 30 -32) . ) reaches approximately 10 -50 mM (16) . Previous studies unveiled that this range of ammonia concentration is toxic for gastric epithelial cells (12 -14, 17, 30 -32) and that the mechanisms involve the prolonged intracellular acidification and the decreased mitochondrial function by suppressing ATP production, resulting in cell death (12 -14, 16, 17, 30 -32) . Thus, a reagent that inhibits the toxic effect of ammonia may be a promising drug for the treatment of gastric diseases caused by H. pylori infection. One of the present authors (EN) reported previously that glutamine potently protected RGM1 cells against ammoniainduced cell death (16) . It is of interest to examine using gerbils the effect of long-term treatment of glutamine on H. pylori-induced pathological changes in the stomach.
In the gerbil stomach, H. pylori infection induces gastritis at 2 weeks, gastric ulcer at 6 months, and then progresses to induce gastric cancer at 15 months with highly stable prevalence (16, 18, 19, 33) . In the present study, we confirmed in 3-month-infected gerbils that severe edema, surface congestion and some bleeding spots were observed in most areas of the gastric corpus, except for the area just close to the greater curvature. In 2-year-infected gerbils, the pathological changes became worse, that is, hyperplastic polyps and abnormal thickened mucosa with severe edema, bleeding, and ulcers were observed. Histological analyses revealed the occurrence of excess mucosal inflammation concomitant with parietal and chief cell atrophy. In addition, intestinal metaplasia was also seen as judged from goblet cells with sialomucin. These pathological changes were similar to those observed in humans (4, 34) , indicating that the experimental system using gerbils is the best animal model for evaluation of H. pylori-induced gastric diseases (8, 18, 19, 33) .
Surprisingly, glutamine as well as marzulene significantly ameliorated the H. pylori-induced pathological changes in the stomach, without affecting the number of viable H. pylori. H. pylori resides outside the body, that is, in the mucus layer of gastric lumen, that is far from the area where the bactericidal action by immune cells directly reaches (4) . It is therefore assumed that the host protective response against H. pylori-derived toxin may be stimulated by glutamine, without direct action on H. pylori. To clarify the mechanisms by which glutamine or the glutamine-containing drug marzulene protects against the H. pylori-induced pathological changes in the stomach, we examined the effect of glutamine on the gastric epithelial responses to ammonia using RGM1 cells in vitro. As expected, the intracellular accumulation of ammonia, the release of chemokine, and the resulting cell death were all potently suppressed by co-treatment with glutamine both in RGM1 cells (rat gastric epithelial cell line) and MKN74 cells (human gastric epithelial-like cell line). It was also noted in the in vitro experiments that glutamine should be co-incubated with ammonia for a longer time to obtain a potent protection. The same is true for the in vivo gerbil experiments. In our previous experiment, glutamine (solution) given three times daily showed less protection against H. pylori-induced gastritis compared with the present results using glutamine-containing diets, which remain in the stomach for much longer (unpublished data). It is thus assumed that glutamine should remain in the lumen of the stomach for a longer time to exert a potent protection. At present, the mechanism by which glutamine protects against H. pylori-induced gastric diseases remains unknown. However, it is assumed that the prophylactic effect of glutamine on ammonia-induced cell damage would mainly account for the protective action against H. pylori-induced gastric diseases, on the basis of the following reasons (16, 35) : 1) many studies suggest the pathogenic importance of urease-derived ammonia in the formation of gastritis induced by H. pylori; 2) ammonia is accumulated in the cells, resulting in an increase in chemokine production and a decrease in cell viability; 3) gastric epithelial cells metabolize ammonia to urea via arginase, a process that is stimulated by glutamine and results in reduced ammonia cytotoxicity; 4) glutamine also inhibits the uptake and facilitates the extrusion of ammonia from cells, resulting in a decrease of chemokine production and cell death. Certainly, other mechanisms should also be involved in the protection by glutamine against H. pylori-induced gastric diseases, yet the elucidation of such mechanisms must await further study, especially using a gerbil infection in vivo model. Given the findings in the present study, we concluded that a high glutamine-or marzulene-containing diet protects the gastric mucosa against H. pylori-induced pathological changes. It may be assumed that facilitation by glutamine of the gastric epithelial function would be an interesting target for the treatment of H. pyloriinduced gastric diseases.
